Daniel Geffken Email & Phone Number

Founder and Managing Director @ Danforth Health

View Daniel's Email & Phone Number

5 free lookup(s). No credit card required.

If you need more lookups, subscriptions start at $34 USD/month.

Daniel Geffken Location

Cambridge, MA, US

Daniel Geffken Work

2011 -now Founder and Managing Director @
2021 -now Interim Chief Financial Officer @
2016 -now Chief Financial Officer @
2020 -2023 Interim Chief Financial Officer @
2021 -2023 Senior Financial Advisor @ Affini-T
2020 -2023 Chief Financial Officer @ Locust Walk Acquisition Corp.
2020 -2023 Interim Chief Financial Officer @ Dermbiont Therapeutics
2016 -2023 Interim Chief Financial Officer @ AnTolRx, Inc.
2018 -2023 Interim Chief Financial Officer @ Apic Bio, Inc.
2021 -2023 Senior Financial Advisor @
2021 -2022 Senior Financial Advisor @
2021 -2022 Interim Chief Financial Officer @
2021 -2022 Senior Financial Advisor @
2020 -2022 Senior Financial Advisor @
2021 -2022 Senior Financial Advisor @
2020 -2022 Senior Financial Advisor @ Palvella Therapeutics
2020 -2022 Senior Financial Advisor @ Matrivax Corporation
2014 -2022 Interim Chief Financial Officer and Director @
2018 -2022 Senior Financial Advisor @ Nia Therapeutics
2017 -2022 Interim Chief Financial Officer @ Vigeo Therapeutics
2019 -2021 Interim Chief Financial Officer @ Zikani Therapeutics
2020 -2021 Interim Chief Financial Officer @
2019 -2020 Senior Financial Advisor @ Graybug Vision, Inc.
2019 -2020 Interim Chief Financial Officer @ Atea Pharmaceuticals
2013 -2020 Interim Chief Financial Officer @ Lysosomal Technologies, Inc.
2012 -2020 Interim Chief Financial Officer @ Promedior, Inc
2018 -2019 Senior Financial Advisor @
2017 -2019 Interim Chief Financial Officer @ Aquinnah Pharmaceuticals
2015 -2019 Senior Financial Advisor @ Kallyope, Inc.
2016 -2019 Interim Chief Financial Officer @
2015 -2019 Senior Financial Advisor @
2018 -2019 Senior Financial Advisor @ ImmunsanT
2015 -2019 Senior Financial Advisor @ Stoke Therapeutics
2017 -2018 Interim Chief Financial Officer @ Recover Together (dba, Groups, Inc.)
2016 -2018 Senior Financial Advisor @ Pear Therapeutics
2016 -2018 Interim Chief Financial Officer @ Entrada Therapeutics, Inc.
2016 -2018 Member Board of Directors @ Vyriad, Inc.
2015 -2018 Interim Chief Financial Officer @ GenePeeks, Inc.
2014 -2018 Senior Financial Advisor @
2017 -2018 Board of Directors @ Arcturus Therapeutics
2015 -2018 Interim Chief Financial Officer @
2015 -2018 Interim Chief Financial Officer @
2017 -2018 Senior Financial Advisor @ Elucida Oncology, Inc.
2015 -2017 Interim Chief Financial Officer @
2013 -2017 Board of Directors; Audit Committee, Compensation Committee @ Alcobra Ltd
2016 -2017 Senior Financial Advisor @ WntRx Pharmaceuticals
2013 -2017 Senior Financial Advisor @
2015 -2017 Interim Chief Financial Officer @ Homology Medicines, Inc.
2015 -2016 Senior Financial Advisor @
2016 -2016 Senior Finanical Advisor @
2015 -2016 Senior Financial Advisor @ Chiasma, Inc.
2014 -2016 Interim Chief Financial Officer @
2014 -2015 Senior Financial Advisor @ Alcresta, Inc.
2015 -2015 Interim Chief Financial Officer @ X4 Therapeutics
2013 -2015 Interim Chief Financial Officer @
2015 -2015 Senior Financial Advisor @
2014 -2015 Senior Financial Advisor @
2013 -2015 Interim Chief Financial Officer @
2015 -2015 Senior Financial Advisor @ H3 Biomedicine
2012 -2015 Senior Financial Advisor @ Anchor Therapeutics
2012 -2015 Chief Financial Officer @ Sideris Pharmaceuticals
2012 -2014 Senior Financial Consultant @ Genocea Biosciences
2012 -2014 Interim Chief Financial Officer @ Novira Therapeutics
2013 -2013 Senior Financial Consultant @
2011 -2013 Interim Chief Financial Officer @ USDS, Inc.
2012 -2013 Interim CFO @ Bionostics, Inc
2012 -2013 Strategic Advisor @ Acusphere
2012 -2012 Strategic Advisor @ InfoBionic, Inc.
2012 -2012 Senior Advisor, Finance and Operations @ Algeta US, LLC
2009 -2011 Chief Operating Officer @ Seaside Therapeutics
now Principal @ Daniel Geffken Consulting, LLC
now Chief Financial Officer @ Codon Devices
now EVP, Chief Financial Officer @
now SVP, Chief Financial Officer @
1997 -2003 SVP, Chief Financial Officer @ Transkaryotic Therapies, Inc.
now VP, Chief Financial Officer @ CytoTherpeutics, Inc.
now Chief Financial Officer @ MedChem Products
now Senior Audit Manager @

Daniel Geffken Education

Harvard Business School
MBA
1985-1987
The Wharton School
B.S. in Economics (Economics)
1975-1979

Daniel Geffken Skills

Investor Relations
Healthcare
Lifesciences
Life Sciences
Leadership
Finance
Biotechnology
Cross-functional Team Leadership
Mergers & Acquisitions
Start-ups
Fundraising
Strategy
Biopharmaceuticals
Financial Services
Venture Capital
Management Consulting
Management
Commercialization
Financial Modeling
Pharmaceutical Industry
Mergers
IPO
Strategic Planning
Drug Development
Due Diligence
Medical Devices
Product Development
Human Resources
Business Valuation
Business Strategy
Consulting
Corporate Development
Sales
Technology Transfer
Mergers and Acquisitions
Cross Functional Team Leadership
Microsoft Office
Financial Analysis
Start Ups
Marketing
Cross Functional Team

Daniel Geffken Summary

Daniel Geffken, based in Cambridge, MA, US, is currently a Founder and Managing Director at Danforth Advisors. Daniel Geffken brings experience from previous roles at Eloxx Pharmaceuticals, ProMIS™ Neurosciences, Inc., CalciMedica and Affini-T. Daniel Geffken holds a 1985 - 1987 MBA @ Harvard Business School. With a robust skill set that includes Investor Relations, Healthcare, Lifesciences, Life Sciences, Leadership and more. Daniel Geffken has 2 emails and 6 mobile phone numbers on RocketReach.